Bridgewater Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-14,397
| Closed | -$237K | – | 756 |
|
2024
Q4 | $237K | Sell |
14,397
-35,957
| -71% | -$593K | ﹤0.01% | 661 |
|
2024
Q3 | $743K | Sell |
50,354
-12,374
| -20% | -$183K | ﹤0.01% | 639 |
|
2024
Q2 | $870K | Buy |
62,728
+38,121
| +155% | +$529K | ﹤0.01% | 687 |
|
2024
Q1 | $387K | Sell |
24,607
-5,226
| -18% | -$82.2K | ﹤0.01% | 643 |
|
2023
Q4 | $483K | Sell |
29,833
-118,513
| -80% | -$1.92M | ﹤0.01% | 707 |
|
2023
Q3 | $1.82M | Buy |
148,346
+21,755
| +17% | +$268K | 0.01% | 509 |
|
2023
Q2 | $2.03M | Sell |
126,591
-6,836
| -5% | -$110K | 0.01% | 456 |
|
2023
Q1 | $2.32M | Buy |
+133,427
| New | +$2.32M | 0.01% | 435 |
|